Shares of Solazyme Inc. (NASDAQ:TVIA) dropped 3.5% during trading on Friday . The company traded as low as $2.48 and last traded at $2.48, with a volume of 61,302 shares. The stock had previously closed at $2.57.

The company has a 50 day moving average price of $2.40 and a 200 day moving average price of $2.06. The firm’s market capitalization is $210.63 million.

Solazyme (NASDAQ:TVIA) last posted its quarterly earnings results on Wednesday, May 4th. The company reported ($0.27) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.29) by $0.02. The business earned $10.90 million during the quarter, compared to analysts’ expectations of $11.94 million. The firm’s revenue for the quarter was down 13.5% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.37) earnings per share. On average, equities research analysts expect that Solazyme Inc. will post ($1.12) EPS for the current fiscal year.

In related news, CFO Tyler Painter sold 12,500 shares of the business’s stock in a transaction that occurred on Tuesday, June 7th. The stock was sold at an average price of $2.67, for a total value of $33,375.00. Following the transaction, the chief financial officer now directly owns 400,337 shares of the company’s stock, valued at approximately $1,068,899.79. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.